Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Total Assets : ¥340.4 Mil (As of Sep. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Total Assets?

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Total Assets for the quarter that ended in Sep. 2023 was ¥340.4 Mil.

During the past 12 months, Hangzhou TianMuShan Pharmaceutical Enterprise Co's average Total Assets Growth Rate was -27.00% per year. During the past 3 years, the average Total Assets Growth Rate was -19.90% per year. During the past 5 years, the average Total Assets Growth Rate was -6.40% per year. During the past 10 years, the average Total Assets Growth Rate was 3.60% per year.

During the past 13 years, Hangzhou TianMuShan Pharmaceutical Enterprise Co's highest 3-Year average Total Assets Growth Rate was 28.40%. The lowest was -19.90%. And the median was 1.70%.

Total Assets is connected with ROA %. Hangzhou TianMuShan Pharmaceutical Enterprise Co's annualized ROA % for the quarter that ended in Sep. 2023 was -5.41%. Total Assets is also linked to Revenue through Asset Turnover. Hangzhou TianMuShan Pharmaceutical Enterprise Co's Asset Turnover for the quarter that ended in Sep. 2023 was 0.12.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Total Assets Historical Data

The historical data trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Total Assets Chart

Hangzhou TianMuShan Pharmaceutical Enterprise Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

479.91

526.93

451.04

402.65

299.84

Hangzhou TianMuShan Pharmaceutical Enterprise Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Assets	Get a 7-Day Free Trial															348.94	299.84	284.21	256.61	340.44

Hangzhou TianMuShan Pharmaceutical Enterprise Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	4.48	+	295.36
	=	299.8

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2023 )	+	Total Liabilities (Q: Sep. 2023 )
	=	-22.362	+	362.804
	=	340.4

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Total Assets Explanation

Total Assets is connected with ROA %.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %	=	Net Income (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	-16.148	/	( (256.606	+	340.443)	/ 2 )
	=	-16.148	/	298.5245
	=	-5.41 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Asset Turnover for the quarter that ended in Sep. 2023 is

	Asset Turnover
=	Revenue (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
=	35.153	/	( (256.606	+	340.443)	/ 2 )
=	35.153	/	298.5245
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Total Assets Related Terms

Thank you for viewing the detailed overview of Hangzhou TianMuShan Pharmaceutical Enterprise Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (SHSE:600671) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.18 Shangyang Road, Jinnan Street, Lin'an District, Zhejiang Province, Hangzhou, CHN, 311300

Website

http://www.hztmyy.com

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China. The company is also engaged in medical device production and sales, cosmetics production, sales, production and sales of sanitary products.

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Headlines

No Headlines